Bio Protocol vs Codatta — how do they compare? Bio Protocol trades at Rp515.06 (market cap Rp1,15T, Rp256,3M 24h volume), while Codatta trades at Rp102.18 (market cap Rp255,84M, Rp59,72M 24h volume). The key difference: Bio Protocol is far larger — about 4495× Codatta's market cap, and Bio Protocol's circulating supply is 2,2B / 3,3B BIO (68%) versus 2,5B / 10B XNY (25%) for Codatta. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and Codatta for 3 Days on average.
| BIO | XNY | |
|---|---|---|
Market Cap | Rp1,15T | Rp255,84M |
Volume (24h) | Rp256,3M | Rp59,72M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 2,5B / 10B XNY (25%) |
Typical Hold Time | 16 Days | 3 Days |
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Codatta is a decentralized infrastructure protocol that converts human and AI-generated knowledge into ownable, royalty-generating digital assets. It enables contributors to fractionalize data and earn ongoing revenue streams. Operating across BNB Chain, Ethereum, and Solana, Codatta provides provenance tracking, licensing, and automated payouts as a plug-and-play backend for AI and DeSci ecosystems.
Read more on XNY →